Guggenheim Capital’s RXR Acquisition Corp. Warrants to purchase Class A common stock RXRAW Stock Holding History

Guggenheim Capital’s Portfolio RXRAW Stock Details RXRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-88,810	Closed	-$1K	–	2025
2022 Q3	$1K	Sell	88,810 -592,707	-87%	-$61.6K	﹤0.01%	1893
2022 Q2	$77K	Sell	681,517 -2,462	-0.4%	-$652	﹤0.01%	2020
2022 Q1	$307K	Buy	683,979 +6,732	+1%	+$3.52K	﹤0.01%	1879
2021 Q4	$473K	Buy	677,247 +7,836	+1%	+$5.9K	﹤0.01%	1708
2021 Q3	$501K	Buy	669,411 +17,377	+3%	+$16.1K	﹤0.01%	1743
2021 Q2	$699K	Buy	+652,034	New	+$535K	﹤0.01%	1668

Guggenheim Capital's RXRAW Position: Q4 2022 in Review

Guggenheim Capital sold out of RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) in Q4 2022, closing a stake of 88,810 shares — an estimated $1K sold.

Guggenheim Capital first reported a position in RXRAW in Q2 2021 and held it in 6 quarters. The position peaked at $699K in Q2 2021. 0 funds tracked by Wall St. Rank hold RXRAW as of Q4 2022.

Guggenheim Capital reported no remaining RXR Acquisition Corp. Warrants to purchase Class A common stock position as of Q4 2022 after selling out during the quarter.
Guggenheim Capital sold 88,810 RXR Acquisition Corp. Warrants to purchase Class A common stock shares in Q4 2022, an estimated $1K.
Guggenheim Capital first reported a position in RXR Acquisition Corp. Warrants to purchase Class A common stock in Q2 2021 and held it in 6 quarters.
Guggenheim Capital's RXR Acquisition Corp. Warrants to purchase Class A common stock position peaked at $699K in Q2 2021.
0 funds tracked by Wall St. Rank held RXR Acquisition Corp. Warrants to purchase Class A common stock as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.